These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31456749)

  • 21. Lowering of T3 and rise in reverse T3 induced by hyperglucagonemia: altered thyroid hormone metabolism, not altered release of thyroid hormones.
    Kabadi UM; Premachandra BN
    Horm Metab Res; 1987 Oct; 19(10):486-9. PubMed ID: 3428867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
    Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
    Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
    Wadwekar D; Kabadi UM
    Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms in the brain-specific thyroid hormone transporter OATP1C1 are associated with fatigue and depression in hypothyroid patients.
    van der Deure WM; Appelhof BC; Peeters RP; Wiersinga WM; Wekking EM; Huyser J; Schene AH; Tijssen JG; Hoogendijk WJ; Visser TJ; Fliers E
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):804-11. PubMed ID: 18410547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Socioeconomic influence on treatment with liothyronine and desiccated thyroid extract in Denmark.
    la Cour JL; Møllehave LT; Medici BR; Jensen CZ; Bjerregaard AA; Nygaard B
    Eur Thyroid J; 2022 Dec; 11(6):. PubMed ID: 36165837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug therapy reviews: management of hypothyroidism.
    Cobb WE; Jackson IM
    Am J Hosp Pharm; 1978 Jan; 35(1):51-8. PubMed ID: 341699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.
    Clyde PW; Harari AE; Getka EJ; Shakir KM
    JAMA; 2003 Dec; 290(22):2952-8. PubMed ID: 14665656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reassessment of combined LT4 and LT3 treatment for hypothyroidism: the prospects for slow-release T3 preparations.
    Duntas LH
    Hormones (Athens); 2005; 4(2):108-10. PubMed ID: 16613813
    [No Abstract]   [Full Text] [Related]  

  • 30. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.
    Escobar-Morreale HF; Botella-Carretero JI; Gómez-Bueno M; Galán JM; Barrios V; Sancho J
    Ann Intern Med; 2005 Mar; 142(6):412-24. PubMed ID: 15767619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased sensitivity of thyrotropin-thyroid hormone feedback control in hypothyroid and athyreotic patients treated with levothyroxine. Is serum triiodothyronine involved?
    Solter D; Solter M
    Ann Endocrinol (Paris); 2018 Apr; 79(2):62-66. PubMed ID: 29530271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual function and depressive symptoms in young men with hypothyroidism receiving levothyroxine/liothyronine combination therapy.
    Krysiak R; Marek B; Okopień B
    Endokrynol Pol; 2018; 69(1):16-22. PubMed ID: 29319127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No role for tri-iodothyronine (T3) testing in the assessment of levothyroxine (T4) over-replacement in hypothyroid patients.
    Livingston M; Birch K; Guy M; Kane J; Heald AH
    Br J Biomed Sci; 2015; 72(4):160-3. PubMed ID: 26738396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scope and limitations of iodothyronine deiodinases in hypothyroidism.
    Gereben B; McAninch EA; Ribeiro MO; Bianco AC
    Nat Rev Endocrinol; 2015 Nov; 11(11):642-652. PubMed ID: 26416219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination Levothyroxine + Liothyronine Treatment in Pregnancy.
    Foeller ME; Silver RM
    Obstet Gynecol Surv; 2015 Sep; 70(9):584-6. PubMed ID: 26403562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 3,5,3'L-triiodothyronine administration on serum thyroid hormone levels in hypothyroid patients maintained on constant doses of thyroxine.
    Inada M; Nishikawa M; Naito K; Ishii H; Tanaka K; Kurata S; Oishi M; Imura H
    Endocrinol Jpn; 1980 Jun; 27(3):291-5. PubMed ID: 7439119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of hypothyroidism therapy with thyroid hormone].
    Fang L; Tan T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Apr; 22(2):396-9. PubMed ID: 15884564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiological relevance of deiodinase polymorphism.
    Bianco AC; Kim BS
    Curr Opin Endocrinol Diabetes Obes; 2018 Oct; 25(5):341-346. PubMed ID: 30063552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine.
    Escobar-Morreale HF; Botella-Carretero JI; Morreale de Escobar G
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):57-75. PubMed ID: 25617173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid hormone replacement therapy.
    Wiersinga WM
    Horm Res; 2001; 56 Suppl 1():74-81. PubMed ID: 11786691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.